Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “amoxicillin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 13
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 13 pipeline programs matching "amoxicillin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

13 results for “amoxicillin” Back to intelligence hub

Search results

  1. Keverprazan Hydrochloride tablets + high dose amoxicillin

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education

    phase 3 small molecule active

    1 trial
  2. T2214

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Diffuse Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial
  3. 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  4. Amoxicillin + MMX placebo

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial
  5. amoxicillin-clavulanic acid

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  6. AMOXICILLIN

    Pari Pharma GmbH

    Adults diagnosed with lower limbs erysipelas

    approved small molecule active

    1 trial
  7. Amoxicillin film-coated tablets for non-specific low back pain

    Disc Medicine

    non-specific low back pain

    approved small molecule active

    1 trial
  8. Amoxicillin/clavulanate

    GlaxoSmithKline

    Focal Infection, Dental

    approved small molecule completed

    1 trial
  9. Vonoprazan and Amoxicillin for the first 7 days

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    approved small molecule active

    1 trial
  10. omeprazole plus amoxicillin

    Hospital Authority, Hong Kong

    Duodenal Ulcer

    approved small molecule completed

    1 trial
  11. Amoxicillin

    Universal Integrated

    Human Gut Microbiota

    small molecule completed

    1 trial
  12. Tegoprazan-amoxicillin dual therapy

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    mab completed

    1 trial
  13. Vonoprazan+amoxicillin+doxycycline+bismuth for 14 days

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.